Frequency and timing of loss of imprinting at 11p13 and 11p15 in Wilms' tumor development

被引:19
作者
Brown, Keith W. [1 ]
Power, Frances [1 ]
Moore, Beth [1 ]
Charles, Adrian K. [2 ]
Malik, Karim T. A. [1 ]
机构
[1] Univ Bristol, Sch Med Sci, CLIC Sargent Res Unit, Dept Cellular & Mol Med, Bristol BS8 1TD, Avon, England
[2] Princess Margaret Hosp Children, Dept Histopathol, Perth, WA, Australia
关键词
D O I
10.1158/1541-7786.MCR-08-0002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epigenetic changes occur frequently in Wilms' tumor (WT), especially loss of imprinting (LOI) of 1GF2/H19 at 11p15. Our previous results have identified imprinted transcripts (WT1-AS and AWT1) from the WT1 locus at 11p13 and showed LOI of these in some WTs. In this article, we set out to test the relationship between LOI at 11 p13 and 11 p15 and their timing in WT progression relative to other genetic changes. We found a higher level (83%) of 11 p13 LOI in WT than of 11 p15 LOI (71%). There was no correlation between methylation levels at the 11 p13 and 11 p15 differentially methylated regions or between allelic expression of WT1-AS/AWT1 and IGF2. Interestingly, retention of normal imprinting at 11p13 was associated with a small group of relatively late-onset, high-stage WTs. An examination of genetic and epigenetic alterations in nephrogenic rests, which are premalignant WT precursors, showed that LOI at both 11 p13 and 11 p15 occurred before either 16q loss of heterozygosity (LOH) or 7p LOH. This suggests that these LOH events are very unlikely to be a cause of LOI but that LOH may act by potentiating the effects of overexpression of IGF2 and/or WT1-AS/AWT1 that result from LOI.
引用
收藏
页码:1114 / 1123
页数:10
相关论文
共 51 条
[1]   Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia:: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour [J].
Astuti, D ;
Latif, F ;
Wagner, K ;
Gentle, D ;
Cooper, WN ;
Catchpoole, D ;
Grundy, R ;
Ferguson-Smith, AC ;
Maher, ER .
BRITISH JOURNAL OF CANCER, 2005, 92 (08) :1574-1580
[2]   ANAPLASTIC WILMS-TUMOR, A SUBTYPE DISPLAYING POOR-PROGNOSIS, HARBORS P53 GENE-MUTATIONS [J].
BARDEESY, N ;
FALKOFF, D ;
PETRUZZI, MJ ;
NOWAK, N ;
ZABEL, B ;
ADAM, M ;
AGUIAR, MC ;
GRUNDY, P ;
SHOWS, T ;
PELLETIER, J .
NATURE GENETICS, 1994, 7 (01) :91-97
[3]  
BECKWITH J B, 1990, Pediatric Pathology, V10, P1
[4]   Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene [J].
Bell, AC ;
Felsenfeld, G .
NATURE, 2000, 405 (6785) :482-485
[5]   Epigenetic specificity of loss of imprinting of the IGF2 gene in Wilms tumors [J].
Bjornsson, Hans T. ;
Brown, Lindsey J. ;
Fallin, M. Danielle ;
Rongione, Michael A. ;
Bibikova, Marina ;
Wickham, Eliza ;
Fan, Jian-Bing ;
Feinberg, Andrew P. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (16) :1270-1273
[6]   LOSS OF CHROMOSOME-11P ALLELES IN CULTURED-CELLS DERIVED FROM WILMS-TUMORS [J].
BROWN, KW ;
SHAW, APW ;
POIRIER, V ;
TYLER, SJ ;
BERRY, PJ ;
MOTT, MG ;
MAITLAND, NJ .
BRITISH JOURNAL OF CANCER, 1989, 60 (01) :25-29
[7]  
BROWN KW, 2001, EXPERT REV MOL MED, P1
[8]   Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development [J].
Charles, AK ;
Brown, KW ;
Berry, PJ .
AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (03) :991-1000
[9]   DEREGULATION OF BOTH IMPRINTED AND EXPRESSED ALLELES OF THE INSULIN-LIKE GROWTH-FACTOR-2 GENE DURING BETA-CELL TUMORIGENESIS [J].
CHRISTOFORI, G ;
NAIK, P ;
HANAHAN, D .
NATURE GENETICS, 1995, 10 (02) :196-201
[10]   Molecular subtypes and phenotypic expression of Beckwith-Wiedemann syndrome [J].
Cooper, WN ;
Luharia, A ;
Evans, GA ;
Raza, H ;
Haire, AC ;
Grundy, R ;
Bowdin, SC ;
Riccio, A ;
Sebastio, G ;
Bliek, J ;
Schofield, PN ;
Reik, W ;
Macdonald, F ;
Maher, ER .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2005, 13 (09) :1025-1032